HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Adams Diversified Equity Fund Inc.

Adams Diversified Equity Fund Inc. boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 63.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,700 shares of the company’s stock after buying an additional 19,200 shares during the quarter. Adams Diversified Equity Fund Inc.’s holdings in HCA Healthcare were worth $14,917,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in HCA. FMR LLC lifted its holdings in HCA Healthcare by 322.3% in the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after buying an additional 2,397,883 shares in the last quarter. Royal London Asset Management Ltd. raised its stake in shares of HCA Healthcare by 62.0% in the 4th quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock valued at $450,461,000 after purchasing an additional 574,239 shares in the last quarter. Principal Financial Group Inc. raised its stake in shares of HCA Healthcare by 120.1% in the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock valued at $262,264,000 after purchasing an additional 476,756 shares in the last quarter. Meritage Group LP acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $150,548,000. Finally, Raymond James Financial Inc. acquired a new stake in shares of HCA Healthcare in the 4th quarter valued at about $74,121,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Stock Down 0.2 %

HCA Healthcare stock opened at $333.68 on Friday. The firm has a market cap of $82.15 billion, a PE ratio of 15.19, a P/E/G ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The firm’s 50 day moving average price is $320.98 and its two-hundred day moving average price is $343.89. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the business posted $5.90 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.86%. HCA Healthcare’s dividend payout ratio is 13.11%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on HCA shares. Truist Financial decreased their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. KeyCorp reduced their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. Finally, Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price target for the company from $400.00 to $320.00 in a research report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.